Randomized phase II study of brostallicin (PNU-166196A) versus doxorubicin as first line chemotherapy in patients with advanced or metastatic soft tissue sarcoma.
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2015
At a glance
- Drugs Brostallicin (Primary) ; Doxorubicin
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 12 Jul 2011 EudraCT reports status as recruiting in United Kingdom and completed in Netherlands and Germany.
- 12 Jul 2011 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database record.
- 06 Jun 2010 Results were presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO 2010).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History